D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $100B
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Quarter Return
+3.64%
1 Year Return
+23.04%
3 Year Return
+72.12%
5 Year Return
+130.88%
10 Year Return
+299.18%
AUM
$56B
AUM Growth
+$56B
Cap. Flow
+$1.9B
Cap. Flow %
3.39%
Top 10 Hldgs %
12.39%
Holding
2,830
New
297
Increased
1,106
Reduced
1,011
Closed
268

Top Sells

1
AAPL icon
Apple
AAPL
$440M
2
NFLX icon
Netflix
NFLX
$300M
3
VZ icon
Verizon
VZ
$253M
4
TSLA icon
Tesla
TSLA
$241M
5
BABA icon
Alibaba
BABA
$236M

Sector Composition

1 Technology 17.21%
2 Healthcare 14.64%
3 Consumer Discretionary 11.67%
4 Communication Services 10.42%
5 Industrials 9.58%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
SGYP
2426
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$65K ﹤0.01%
28,964
-6,385
-18% -$14.3K
STLRW
2427
DELISTED
Stellar Acquisition III Inc. Warrants
STLRW
$64K ﹤0.01%
205,000
SGY.WS
2428
DELISTED
Stone Energy Corporation Warrants to purchase common stock (expiring February 28, 2021)
SGY.WS
$64K ﹤0.01%
12,800
CASC
2429
DELISTED
Cascadian Therapeutics, Inc.
CASC
$62K ﹤0.01%
16,846
+2,400
+17% +$8.83K
ELDN icon
2430
Eledon Pharmaceuticals
ELDN
$155M
$61K ﹤0.01%
15,679
ALTO icon
2431
Alto Ingredients
ALTO
$87.5M
$60K ﹤0.01%
13,133
-1,180
-8% -$5.39K
AGTC
2432
DELISTED
Applied Genetic Technologies Corporation
AGTC
$58K ﹤0.01%
+15,990
New +$58K
BRACR
2433
DELISTED
Black Ridge Acquisition Corp. Right
BRACR
$57K ﹤0.01%
+203,900
New +$57K
IBRX icon
2434
ImmunityBio
IBRX
$2.29B
$54K ﹤0.01%
+12,028
New +$54K
AVXL icon
2435
Anavex Life Sciences
AVXL
$831M
$52K ﹤0.01%
+16,140
New +$52K
BRACW
2436
DELISTED
Black Ridge Acquisition Corp. Warrant
BRACW
$49K ﹤0.01%
+147,449
New +$49K
WLB
2437
DELISTED
Westmoreland Coal Company
WLB
$47K ﹤0.01%
38,455
-64,668
-63% -$79K
MMDMW
2438
DELISTED
Modern Media Acquisition Corp. Warrant
MMDMW
$45K ﹤0.01%
89,000
MMDMR
2439
DELISTED
Modern Media Acquisition Corp. Right
MMDMR
$45K ﹤0.01%
115,300
SRNE
2440
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$42K ﹤0.01%
+11,000
New +$42K
SMRT
2441
DELISTED
Stein Mart Inc
SMRT
$41K ﹤0.01%
35,377
+12,181
+53% +$14.1K
ANTH
2442
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$41K ﹤0.01%
+24,606
New +$41K
BCIC
2443
BCP Investment Corporation Common Stock
BCIC
$162M
$35K ﹤0.01%
10,410
RGLS
2444
DELISTED
Regulus Therapeutics
RGLS
$28K ﹤0.01%
27,319
-2,409
-8% -$2.47K
GST
2445
DELISTED
Gastar Exploration Inc.
GST
$25K ﹤0.01%
23,963
-4,600
-16% -$4.8K
ARQL
2446
DELISTED
Arqule Inc
ARQL
$22K ﹤0.01%
13,624
-687,474
-98% -$1.11M
MVIS icon
2447
Microvision
MVIS
$343M
$21K ﹤0.01%
12,878
-8,271
-39% -$13.5K
SDRL
2448
DELISTED
Seadrill Limited Common Stock
SDRL
$3K ﹤0.01%
11,060
CYHHZ
2449
DELISTED
Community Health Systems, Inc. Series A Contingent Value Rights
CYHHZ
$1K ﹤0.01%
99,900
AVXS
2450
DELISTED
AveXis, Inc. Common Stock
AVXS
0